rhuFVIIa in Post-partum Hemorrhage

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Postpartum Hemorrhage
Interventions
DRUG

rFVIIa

The patients included in this arm of the study will recieve standard care for post-partum hemorrhage plus a slow intravenous injection (2ml/min) of rFVIIa (60µg/kg)

PROCEDURE

Standard Care

Patients will recieve standard care for post partum hemorrhage according to current recommendations.

Trial Locations (8)

Unknown

University Hospital, Lille, Lille

University Hospital of Montpellier, Montpellier

University Hospital, Nice, Nice

Hôpital Antoine Béclère -APHP, Clamart

Centre Hospital University of Nimes, Nîmes

Maternite CHU de Cochin - APHP, Paris

University Hospital, Geneva, Geneva

F-30029

Laboratoire d'hématologie, Groupe Hospitalo-Universitaire Caremeau, Nîmes

All Listed Sponsors
collaborator

University Hospital, Lille

OTHER

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

collaborator

University Hospital, Montpellier

OTHER

collaborator

University Hospital, Geneva

OTHER

collaborator

Centre Hospitalier Universitaire de Nice

OTHER

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT00370877 - rhuFVIIa in Post-partum Hemorrhage | Biotech Hunter | Biotech Hunter